TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2023-09-19
蔡力凱TSAI, LI-KAI
- 計畫主持人
- 執行臨床試驗年資 17 年 9 個月
發表文獻
25筆
1
Tsai LK, Chen PL, Tsai HH, Chen YF, Wu PC, Jeng JS, Huang JW, Chu TS, Tze-Wah Kao J. Cerebral Microbleeds in Autosomal Dominant Polycystic Kidney Disease. J Stroke. 2020 Jan;22(1):153-156. doi: 10.5853/jos.2019.02838. Epub 2020 Jan 31. PMID: 32027801; PMCID: PMC7005356.
2
Lin HY, Tsai LK, Cheng YC, Lu HE, Huang CY, Hsieh PCH, Lin CH. Generation of a human induced pluripotent stem cell (iPSC) line (IBMS-iPSC-048-05) from a patient with ALS and parkinsonism having a hexanucleotide repeat expansion mutation in C9orf72 gene. Stem Cell Res. 2020 Apr;44:101734. doi: 10.1016/j.scr.2020.101734. Epub 2020 Feb 27. PMID: 32151952.
3
Lin SY, Tang SC, Tsai LK, Yeh SJ, Huang CF, Jeng JS. Factors for recurrent stroke among Asian patients with non-valvular atrial fibrillation under non-vitamin K antagonist oral anticoagulant therapy. J Formos Med Assoc. 2020 Dec;119(12):1799-1806. doi: 10.1016/j.jfma.2020.02.003. Epub 2020 Feb 24. PMID: 32107099.
4
Hsueh SJ, Chen CH, Yeh SJ, Lin YH, Tsai LK, Lee CW, Tang SC, Jeng JS. Early recurrence of ischemic stroke in patients receiving endovascular thrombectomy. J Formos Med Assoc. 2021 Feb;120(2):854-862. doi: 10.1016/j.jfma.2020.09.007. Epub 2020 Sep 19. PMID: 32962887.
5
Chen SJ, Yeh SJ, Tang SC, Lin SY, Tsai LK, Jeng JS. Similar outcomes between vitamin K and non-vitamin K antagonist oral anticoagulants associated intracerebral hemorrhage. J Formos Med Assoc. 2020 Jan;119(1 Pt 1):106-112. doi: 10.1016/j.jfma.2019.02.008. Epub 2019 Mar 12. PMID: 30876786.
6
Lin SY, Kuo CH, Yeh SJ, Tsai LK, Liu YB, Huang CF, Tang SC, Jeng JS. Real-World Rivaroxaban and Apixaban Levels in Asian Patients With Atrial Fibrillation. Clin Pharmacol Ther. 2020 Jan;107(1):278-286. doi: 10.1002/cpt.1601. Epub 2019 Sep 14. PMID: 31376150; PMCID: PMC6977317.
7
Tsai HH, Lee BC, Huang CY, Tsai LK, Tang SC, Jeng JS, Chen YF. Asymptomatic Striatocapsular slit-like Hemorrhage as a Severity Marker in Patients with Hypertensive Angiopathy. J Stroke Cerebrovasc Dis. 2020 Oct;29(10):105153. doi: 10.1016/j.jstrokecerebrovasdis.2020.105153. Epub 2020 Jul 29. PMID: 32912549.
8
Chen YA, Tsai YC, Chen YD, Liu DZ, Young TH, Tsai LK. Intraventricular Medium B Treatment Benefits an Ischemic Stroke Rodent Model via Enhancement of Neurogenesis and Anti-apoptosis. Sci Rep. 2020 Apr 20;10(1):6596. doi: 10.1038/s41598-020-63598-0. PMID: 32313130; PMCID: PMC7171187.
9
Liu TY, Wang CH, Chiang WC, Tang SC, Tsai LK, Lee CW, Jeng JS, Ma MH, Hsieh MJ, Lee YC. Redistributing medical resources for a bypass strategy for large vessel occlusion: a community-based study. J Neurointerv Surg. 2020 Jan;12(1):98-103. doi: 10.1136/neurintsurg-2019-014851. Epub 2019 Jun 13. PMID: 31197027.
10
Tsai LK, Lee IH, Chen YL, Chao TF, Chen YW, Po HL, Lien LM, Chu PH, Huang WC, Lin TH, Lin MT, Jeng JS, Hwang JJ. Diagnosis and Treatment for embolic stroke of undetermined source: Consensus statement from the Taiwan stroke society and Taiwan society of cardiology. J Formos Med Assoc. 2021 Jan;120(1 Pt 1):93-106. doi: 10.1016/j.jfma.2020.05.026. Epub 2020 Jun 10. PMID: 32534996.
